|
| THWS15 |
Overcoming Intellectual Property Barriers to Enable Access to Affordable Antiretrovials: Pricing and Patent Toolkits and Sharing of Successful Strategies from Brazil, India and South Africa |
| |
Community Skills Development
|
| Venue: |
Mini Room 7 |
| Time: |
26.07.2012, 14:30 - 18:00 |
Language: English
Level: Intermediate
Target audience: Advocate, Physician
Seating limits: 100 |
|
Co-Facilitators:
|
Judit Rius Sanjuan, United States
Mandeep Dhaliwal, United States
Michelle Childs, United Kingdom
Nonkosi Khumalo, South Africa
Leena Menghaney, India
Felipe Carvalho, Brazil
|
| |
| |
|
| Enabling price reductions through generic competition is the most sustainable mechanism to ensure affordable access to antiretrovirals. But generic competition is threatened by new intellectual property (IP) barriers that extend pharmaceutical monopolies and keep drug prices high. Safeguards available in international law and used to mitigate IP barriers when public health needs exist are increasingly important. Drawing on new tools and case studies from South Africa, Brazil, and India, this workshop will empower participants to identify IP barriers and assess the impact on specific medical products. The focus will be on design campaigns to implement legal and policy actions, including compulsory licenses, patent oppositions, and stricter patentability requirements. Participants also will learn how to use various practical tools, including Medecins Sans Frontieres/Doctors Without Borders (MSF) new patent opposition database, and patent and pricing search tools, including the United Nations Development Program's patent methodology, and MSF's 'Untangling the Web of Antiretroviral Price Reductions'. |
|
|
14:30
THWS1501 | Introduction and learning objectives
| 14:35
THWS1502
Powerpoint | Overview of intellectual property law and public health safeguards
J. Rius Sanjuan, United States
| 14:50
THWS1503
Powerpoint | Why patent landscapes are needed and what tools do we have available: presentation of UNDP patent methodology
M. Dhaliwal, United States
| 15:00
THWS1504
Powerpoint | Presentation of MSF's untangling the web of antiretroviral price reductrions
A. Bozadjian, Switzerland
| 15:10
THWS1505
Powerpoint | Presentation of patent opposition database
F. Carvalho, Brazil
| 15:20
THWS1506
Powerpoint | Group exercise and discussion
L. Menghaney, India
F. Carvalho, Brazil
M. Di Giano, Argentina
| 16:00
THWS1507 | Break
| 16:15
THWS1508
Powerpoint | The Indian experience: the use of patent oppositions and patentability criteria
L. Menghaney, India
| 16:30
THWS1509
Powerpoint | The Brazilian experience: the campaigns for access to efavirenz and lopinavir/ritonavir
M. Vieira, Brazil
| 16:45
THWS1510
Powerpoint | The South African experience: the campaign to reform South Africa's patent law
N. Hoboyi, South Africa
| 17:00
THWS1511 | Discussion and closing
M. Dhaliwal, United States
M. Childs, United Kingdom
|
|
| Powerpoints presentations |
| Overview of intellectual property law and public health safeguards - Judit Rius Sanjuan | |
| Why patent landscapes are needed and what tools do we have available: presentation of UNDP patent methodology - Mandeep Dhaliwal | |
| Presentation of MSF's untangling the web of antiretroviral price reductrions - Arax Bozadjian | |
| Presentation of patent opposition database - Felipe Carvalho | |
| Group exercise and discussion - | |
| The Indian experience: the use of patent oppositions and patentability criteria - Leena Menghaney | |
| The Brazilian experience: the campaigns for access to efavirenz and lopinavir/ritonavir - Marcela Vieira | |
| The South African experience: the campaign to reform South Africa's patent law - Nokhwezi Hoboyi | |
|
|